Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
31.6M
-
Shares change
-
-777K
-
Total reported value, excl. options
-
$54.3M
-
Value change
-
-$1.13M
-
Number of buys
-
32
-
Number of sells
-
-48
-
Price
-
$1.72
Significant Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q2 2023
104 filings reported holding KRON - Kronos Bio, Inc. - Common Stock as of Q2 2023.
Kronos Bio, Inc. - Common Stock (KRON) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.6M shares
.
Largest 10 shareholders include Omega Fund Management, LLC (3.82M shares), BVF INC/IL (2.81M shares), Vida Ventures Advisors, LLC (2.77M shares), PERCEPTIVE ADVISORS LLC (1.75M shares), PARTNERS CAPITAL INVESTMENT GROUP, LLP (1.67M shares), VANGUARD GROUP INC (1.6M shares), Artal Group S.A. (1.54M shares), Nextech Invest Ltd. (1.45M shares), Alphabet Inc. (1.44M shares), and BlackRock Inc. (1.4M shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.